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Summary
PRINCIPLES: Patients with carotid artery stenosis (CAS)
are at risk of ipsilateral stroke and chronic compromise of
cerebral blood flow. It is under debate whether the hypo-
perfusion or embolism in CAS is directly related to cog-
nitive impairment. Alternatively, CAS may be a marker for
underlying risk factors, which themselves influence cogni-
tion. We aimed to determine cognitive performance level
and the emotional state of patients with CAS. We hypothes-
ised that patients with high grade stenosis, bilateral sten-
osis, symptomatic patients and/or those with relevant risk
factors would suffer impairment of their cognitive perform-
ance and emotional state.
METHODS: A total of 68 patients with CAS of ≥70% were
included in a prospective exploratory study design. All pa-
tients underwent structured assessment of executive func-
tions, language, verbal and visual memory, motor speed,
anxiety and depression.
RESULTS: Significantly more patients with CAS showed
cognitive impairments (executive functions, word produc-
tion, verbal and visual memory, motor speed) and anxiety
than expected in a normative sample. Bilateral and symp-
tomatic stenosis was associated with slower processing
speed. Cognitive performance and anxiety level were not
influenced by the side and the degree of stenosis or the
presence of collaterals. Factors associated with less co-
gnitive impairment included higher education level, female
gender, ambidexterity and treated hypercholesterolemia.
CONCLUSIONS: Cognitive impairment and increased
level of anxiety are frequent in patients with carotid stenos-
is. The lack of a correlation between cognitive functioning
and degree of stenosis or the presence of collaterals, chal-
lenges the view that CAS per se leads to cognitive impair-
ment.
Key words: carotid artery stenosis; CAS; cognitive
function; emotional state
Introduction
Patients with carotid artery stenosis (CAS) are at risk of
chronically reduced cerebral blood flow and recurrent em-
boli to the brain. Reports on cognitive performance in pa-
tients with CAS vary widely: some studies report cognitive
impairment [1–3] even in asymptomatic patients without
history of stroke [4–6], whereas others suggest no cognitive
deficits [7]. A systematic review addressing cognitive per-
formance in patients with symptomatic and asymptomatic
CAS reported cognitive deficits in 14 out of 18 studies [8].
Differences in study results are likely due to variations in
patients’ characteristics, sample size, study design, assess-
ment methods, interpretation of results and also publication
bias and hence, comparison of studies is difficult.
Two probable mechanisms relating to cognitive impair-
ment in carotid artery disease are hypoperfusion and em-
bolisation, both of which decrease the cerebral blood sup-
ply. According to the ‘Spencer curve’ [9], the brain blood
perfusion remains stable in mild and moderate CAS, and
decreases only when high-grade CAS occurs [10]. Cognit-
ive performance is likely determined not only by the degree
of stenosis but also by an interaction of various factors, in-
cluding advanced age [5] and the location of stroke [6, 11].
Arguments against the hypothesis that embolisation causes
cognitive impairment come from the Tromsø Study [4] and
the Cardiovascular Healthy Study [5]. These studies sug-
gested that cognitive performance in patients with CAS
was independent of vascular lesions. The Tromsø Study
found a graded relationship between the degree of CAS
and cognitive performance, which points towards the cru-
cial role of haemodynamic mechanisms. However, in most
patients of the Tromsø Study, the degree of stenosis was
low and hence unlikely to significantly influence haemody-
namic mechanisms.
A further controversial issue is whether CAS directly
causes cognitive impairment or whether it is a marker for
underlying risk factors that predispose patients to cognitive
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impairment. CAS is related to a number of risk factors such
as hypertension, diabetes mellitus, smoking and dyslip-
idemia. Each of these risk factors may influence cognitive
performance [12]. A direct intervention, such as endarter-
ectomy or stenting, may only prevent cognitive decline if
the carotid artery disease itself is the cause of cognitive
impairment. If there is no direct association between sten-
osis and cognitive impairment, treatment of the risk factor
itself will more efficiently influence cognitive impairment.
A comparison study described no difference between
endarterectomy or stenting in effect on cognition [13].
The aim of the present prospective study was to assess
cognition and the emotional state of a large sample of pa-
tients with symptomatic and asymptomatic CAS. We hy-
pothesised that patients with high grade stenosis, bilateral
stenosis, symptomatic patients and/or those with relevant
risk factors would suffer impairment of their cognitive per-
formance and emotional state. Results of the present study
should add a further aspect in therapeutic decision taking in
patients with CAS and aid in the assessment of the benefits
of available treatment modalities.
Methods
Patients: Between 2009 and 2012, 94 patients with CAS
were recruited from the stroke units, outpatient stroke clin-
ic, and the neuroradiology departments at two university
hospitals. In this prospective exploratory study, consenting
patients with enough time for a neuropsychological assess-
ment before intervention were consecutively included in
the trial. Patients with extracranial CAS of ≥70%, were in-
cluded (see details below). They were considered sympto-
matic if a minor stroke (modified Rankin Scale ≤2 at time
of inclusion) or transient ischemic attack (TIA) with either
motor, sensory, speech or visual impairment had occurred
within three months prior to inclusion. Exclusion criter-
ia were major stroke, progressive cerebral pathology (such
as tumour, multiple sclerosis, Alzheimer’s disease), and
Table 2: Risk factors.
yes (n) %
Arterial hypertension 46 67.6
Diabetes mellitus 17 25.0
Hypercholesterolemia 48 70.6
Smoking
current
non smoker for last 5 years
11
7
16.7
10.3
Atrial fibrillation 5 7.4
Table 1: Neuropsychological assessments.
Function Test Reference
Executive Functions
Stroop naming
Stroop reading
Delis-Kaplan Executive Function System (D-KEFS; [34])
Symbols Wechsler Intelligenztest für Erwachsene (WIE; [35])
Processing speed
TMT A time* Consortium to Establish a Registry for Alzheimer's
Disease (CERAD-Plus; [36])
Interference control Stroop interference Delis-Kaplan Executive Function System (D-KEFS; [34])
Shifting TMT B time* Consortium to Establish a Registry for Alzheimer's
Disease (CERAD-Plus; [36])
Language
Word production Boston naming Consortium to Establish a Registry for Alzheimer's
Disease (CERAD-Plus; [36])
Verbal fluency Animal naming Consortium to Establish a Registry for Alzheimer's
Disease (CERAD-Plus). Norms see [37]
Verbal Memory
Episodic memory Word rey
Learning (Σ trial 1 to 5)
Recognition (immediately)
Late recall (after 40 min)
Verbaler Lern- & Merkfähigkeitstest (VLMT; [38])
Short term memory Digit span Wechsler Intelligenztest für Erwachsene (WIE; [35])
Visual Memory
Signs
Learning (Σ trial 1 to 5)
Recognition (immediately)
Late recall (after 40 min)
Rey Visual Design Learning Test (RVDLT; [39])Episodic memory
Rey Osterrieth Complex Figure
Copy
Immediate recall
Late recall (after 45 min)
Rey Osterrieth Figure [40, 41]
Emotional State
Anxiety
Depression
HADS Hospital Anxiety and Depression Scale [42]
Norms see [43]
Motor Speed PPD
Dominant hand
Non-dominant hand
Purdue Pegboard Norms [44]
Note: *TMT A, Trail making test Part A; *TMT B, Trail making test Part B; HADS: Hospital Anxiety and Depression Scale; PPD: Purdue Pegboard
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standard exclusion criteria for magnetic resonance (MR)
imaging. We determined the required sample size accord-
ing to the power analysis by Cohen [14]. With an alpha-
level <0.05, a large effect size = .50 and power = .80 we
aimed to recruit a minimum of 26 patients. The study pro-
tocol was approved by the corresponding local ethics com-
mittees and was conducted according to the Declaration of
Helsinki. Written informed consent was obtained from all
patients prior to study inclusion.
Degree of stenosis and collaterals: The degree of CAS was
determined based on Duplex ultrasound. Peak systolic ve-
locities of >215 were graded as stenosis of ≥70%. Near oc-
clusion was defined as visible plaque that led to marked
narrowing of the lumen, and occlusion was defined as no
detectable patent lumen seen on colour Doppler ultrasound.
If Duplex data were unavailable, data from digital subtrac-
tion angiography, CT- or MR- angiography were used in-
stead. The degree of stenosis was defined according to the
North American Symptomatic Carotid Endarterectomy Tri-
al (NASCET) criteria [15]. Collateralisation was assessed
by categorising the completeness of the circle of Willis as
determined on time-of-flight MR angiography images. The
completeness of the circle of Willis was categorised into
three groups according to Ryan and colleagues [16]: clas-
sical complete circle of Willis (entirely normal circle of
Willis), hypoplastic group (hypoplasia but no absent ves-
sels) and incomplete circle of Willis (absent vessels).
Neuropsychological assessment: Eleven well-known
standardised neuropsychological tests were selected cover-
ing a wide range of cognitive functions (table 1). Patients’
scores were compared to age-, sex- and education adjusted
normative scores of the tests indicated in the respective test
manuals. Risk factors were assessed in an interview (see
table 2). Handedness was measured using the Laterality In-
dex of Oldfield [17] modified after Salmaso & Longoni
[18]. Trained psychologists carried out the neuropsycholo-
gical assessment in the same order and in a standardised
fashion, with a break after 90 minutes. The total assessment
lasted 3 hours (table 1).
Analysis: All statistical analyses were conducted using
IBM SPSS Statistics 20.0 for Windows. As we used ex-
plorative analyses, statistical tests were two-sided with a
5% significance level. Continuous variables were tested for
normal distribution using the Kolmogorov-Smirnov test.
The majority of the variables were not normally distrib-
uted. Consequently, non-parametric tests were used over all
variables, hence mean rank scores are reported in the sup-
plementary table. To unify scores from different tests, z-
scores were calculated for each individual test score. Cog-
nitive impairment was defined according to the standard of
many clinical institutions: deficient cognitive performance
was defined if a cognitive test score was more than 1 stand-
ard deviation below the mean of the normative sample giv-
en in the test manual. The patient group was compared with
the norms given in the respective test manual by using Chi-
Square Test. Mann-Whitney-U Test was used to compare
two subgroups (e.g., symptomatic vs. asymptomatic, wo-
men vs. men, collaterals vs. no collaterals). Kruskal-Wallis-
Test was applied to detect group differences among three
subgroups (degree of stenosis, side of stenosis, circle of
Willis). Spearman's correlation was performed to define the
strength of the association between cognitive performance
and: (1) emotional state (2) number of risk factors, and (3)
the time between symptoms and cognitive assessment. The
numbers of patients (n) was inconsistent due the fact that
some tests were only performed in patients ≥70 years or
<70 years (e.g., visual memory: signs and Rey-Figure; see
table 4).
Results
A total of 68 patients (52 male, 16 female; mean age 68.7
years, range 51.3–85.3 years) were included based on the
aforementioned inclusion criteria. Reasons for drop-out
were stenosis grade <70% (n = 13), intracranial instead of
extracranial stenosis (n = 5), severe stroke (n = 2) and miss-
ing neuropsychological data (n = 6). For demographic and
medical characteristics see tables 2 and 3.
Table 3: Patient demographics and medical characteristics.
n %
male 52 76.5Gender
female 16 23.5
1 14 20.6
2 47 69.1
Education Level
3 7 10.3
right 55 80.9
left 3 4.4
Handedness
both 10 14.7
right 29 42.7
left 27 39.7
Side of Stenosis
bilateral 12 17.6
70% to near occlusion 40 58.8
near occlusion 12 17.6
Degree of Stenosis
total occlusion 16 23.5
complete 5 7.3
hypoplastic 18 26.5
Collaterals
incomplete 45 66.2
symptomatic 23 33.8Symptoms
asymptomatic 45 66.2
Note: Education Level 1 = <9 years, 2 = 9–12 years, 3 = >12 years
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Overall, 30% of patients showed impairment in processing
speed (Stroop Naming, Symbols), 32% in interference con-
trol (Stroop Interference), 26% in word production (Boston
Naming), 30% in verbal episodic memory (Word Rey
learning), 33% in visual episodic memory (Signs learning
and recall), 50% in visuospatial abilities (Rey Figure copy,
31% in late recall), 38% in motor speed of the dominant
hand and 34% of all patients showed impaired motor speed
of the non-dominant hand. In all these tests significantly
more patients showed impairment than expected in a norm-
ative sample. The differences between the observed and
expected frequency of impairment were statistically signi-
ficant (see table 4). Patients showed significantly more of-
ten anxiety but less often depressive symptoms than expec-
ted in a normative sample (table 4). Positive correlations
between processing speed (Symbols) and emotional state
(anxiety r = .26, p = .029; depression r = .27, p = .027) as
well as between verbal fluency and emotional state (anxi-
ety r = .26, p = .035; depression r = .32, p = .008) were ob-
served.
The degree of stenosis did not affect any cognitive domain
(Supplementary table). Patients with bilateral stenosis (n
= 12) showed slowest processing speed (Stroop Reading;
Supplementary table). Asymptomatic patients (n = 45)
showed significantly faster processing speed (trail making
test, TMT A) and dominant hand motor speed than symp-
tomatic patients (n = 23; Supplementary table). Presence
of collaterals did not influence cognitive performance, not
even if degree of stenosis was considered. Risk factors
for CAS (table 2) were related to cognitive performance
level. Patients with hypertension (n = 46) showed signific-
antly worse motor speed (non-dominant hand) than patients
without hypertension (U = 306.0, p = .049). Patients with
atrial fibrillation (n = 5) performed significantly worse in
the domains of processing speed (Symbols, U = 46.0, p =
.009), visuospatial ability (Rey Figure copy, U = 3.5, p =
.034) and motor speed (non-dominant hand, U = 53.5, p
= .021). Patients with hypercholesterolemia (n = 48) per-
formed significantly better than patients without hypercho-
lesterolemia in verbal and visual episodic memory (Words
Rey learning, U = 329.0, p = .041; Words Rey late re-
call, U = 277.0, p = .006; Rey Figure late recall, U = 82.0,
p = .025). With regard to the risk factors diabetes mel-
litus, coronary artery disease, thrombophilia and smoking,
groups did not differ in any cognitive domain. There was a
significant negative correlation between the number of risk
factors and motor speed (dominant hand r = –.34, p = .007;
non-dominant hand r = –.42, p = .001).
Cognitive performance was controlled for additional influ-
encing variables. In symptomatic patients, a longer time
interval between stroke or TIA and neuropsychological
assessment was correlated with faster processing speed
(Symbols: r = .48, p = .031). Patients with a higher edu-
cation level showed better interference control (Stroop In-
terference H(2) = 7.5, p = .023 and better verbal fluency
H(2) = 11.1, p = .004). Women performed significantly bet-
ter than men in visual learning (Signs learning, U = 38, p
= .034), visual recognition (Signs recognition, U = 40.0, p
Table 4: Significant differences between observed and expected cognitive impairments.
Neuropsychological test No of patients with
impairment
No of subjects expected to
show impairment#
Chi-
Square
(χ2)
p
Executive functions
Processing Speed Stroop naming
Stroop reading
Symbols
TMT A time
21
11
18
2
10
10
11
11
14.3
0.1
5.3
8.8
<.001
.731
.021
.003
***†
*
** ‡
Interference Control Stroop interference 22 10 17.0 <.001 ***†
Shifting TMT B time 15 10 3.0 .084
Language
Word production Boston naming 18 11 5.3 .021 *
Verbal fluency Animal naming 7 11 1.7 .188
Verbal Memory
Episodic memory Word rey learning
Word rey recognition
Word rey late recall
21
7
16
11
11
11
10.8
1.7
2.7
.001
.188
.100
**
Short term memory Digit span 15 11 1.7 .188
Visual Memory
Episodic memory Signs learning
Signs recognition
Signs late recall
Rey figure copy
Rey figure immediate recall
Rey figure late recall
10
3
10
18
6
11
5
5
5
6
6
6
6.0
1.0
6.0
28.0
0.0
5.0
.014
.327
.014
<.001
1.000
.025
*
*
***†
*
Emotional State
Anxiety HADS 17 11 3.9 .048 *
Depression HADS 4 11 5.3 .021 *‡
PPD dominant hand 24 10 23.3 <.001 ***†Motor Speed
PPD non-dominant hand 21 10 14.4 <.001 ***†
Note: * p < .05, ** p <.01, *** p <.001: significantly worse than expected in a normative sample; # according to the test manual; † p remains
significant after Bonferroni correction; ‡ significantly better than expected in a normative sample; observed cognitive impairment ≤-1 SD; TMT A:
Trail making test Part A; TMT B: Trail making test Part B; PPD: Purdue Pegboard; HADS: Hospital Anxiety and Depression Scale
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= .030) and visual recall (Signs recall, U = 38.5, p = .037).
Handedness was related to cognitive performance with am-
bidextrous patients showing best performance in interfer-
ence control (Stroop interference: H(2) = 6.7, p = .033),
word production (Boston Naming: H(2) = 8.2, p = .016)
and processing speed (TMT A: H(2) = 7.0, p = .031).
Discussion
The present study presents evidence that patients with CAS
of ≥70% may be at higher risk for cognitive impairment
in some executive domains, word production, verbal and
visual memory and motor speed. Surprisingly, processing
speed was less often impaired in patients with CAS. Anxi-
ety was increased more often than expected in a normative
sample. Bilateral and symptomatic stenosis was related to
slower processing speed but the degree of stenosis did not
influence cognitive performance and anxiety level.
Our detailed cognitive results show that in case of CAS,
complex higher-order cognitive functions such as process-
ing speed and interference control are likely to decline first,
since these require a large amount of cognitive capacity.
The findings of our study are in agreement with earlier re-
ports (using some of the same neuropsychological tests as
the present study), in which deficits in executive functions,
verbal and visual memory, and visuospatial tasks were de-
tected in both symptomatic and asymptomatic patients be-
fore carotid endarterectomy [19]. In routine neurological
practice, assessment of frontal lobe functions is lacking,
since higher order executive functions are not included in
the commonly used mini mental state examination [20].
Hence, impairment of executive functions is likely to be
missed.
Our data as well as that in previous studies [21] suggest that
cognition and emotion are intertwined. We detected a low
positive correlation between executive functions (process-
ing speed, verbal fluency) and the degree of anxiety and de-
pression. Considering the low correlation coefficients, data
has to be interpreted with caution. Still, low executive per-
formance may relate to an increased risk for emotional dis-
turbances. Despite the link between cognition and emotion,
the emotional state is rarely assessed in patients with ca-
rotid artery disease. The increased anxiety of our patients
sample may occur due to fearfulness about the treatment
procedure or concern regarding their general health status.
After treatment of CAS with revascularisation techniques,
the emotional state is likely to improve (see [22]). We
present evidence of the importance of evaluating not only
cognitive functions but also the emotional state when
screening patients with CAS in order to adequately prepare
them for the coming treatment procedure and discussing
concerns and worries.
According to our study results, cognitive performance is
impaired independent of the degree of stenosis. However,
Supplementary Table: Mean Rank scores across all neuropsychological tests.
Degree of stenosis Condition Side
Neuropsychological test >70% near
occl
total
occl
p sympt asympt p right left bilat p
n = 40 n = 12 n = 16 n = 23 n = 45 n = 29 n = 27 n = 12
Executive Functions
Processing Speed Stroop naming
Stroop reading
Symbols
TMT A time
34.5
35.0
34.9
34.1
30.5
32.5
31.5
32.9
33.5
30.7
33.5
37.0
.818
.735
.869
.975
30.3
34.5
30.1
27.0
35.2
32.9
36.1
37.4
.313
.649
.232
.040*
38.6
40.0
34.8
34.2
31.4
30.7
35.1
35.5
26.0
24.3
29.7
30.1
.126
.036*
.693
.725
Interference
Control
Stroop interference 34.9 24.0 37.3 .150 30.4 35.2 .337 35.6 32.7 30.1 .676
Shifting TMT B time 31.6 31.6 31.2 .998 27.6 33.4 .240 30.9 36.7 21.6 .070
Language
Word production Boston naming 32.6 37.5 36.9 .639 31.7 35.9 .395 38.0 33.2 29.0 .367
Verbal fluency Animal naming 35.4 31.6 34.6 .845 28.7 37.5 .083 34.7 34.9 32.9 .954
Verbal Memory
Episodic memory Word rey learning
Word rey recognition
Word rey late recall
33.2
33.6
33.0
41.1
44.8
40.2
32.9
29.0
33.9
.436
.082
.532
34.7
36.9
37.7
34.4
33.3
32.9
.958
.447
.335
37.6
37.3
39.4
34.7
35.6
32.6
26.5
25.5
27.4
.255
.177
.149
Short term
memory
Digit span 34.9 31.9 35.6 .872 36.4 33.5 .577 36.5 37.5 23.0 .083
Visual Memory
Episodic memory Signs learning
Signs recognition
Signs late recall
Rey figure copy
Rey figure immediate recall
Rey figure late recall
14.9
15.0
15.5
17.3
19.8
19.5
18.1
17.6
18.2
20.9
18.2
17.3
14.6
14.9
12.2
19.3
16.5
17.5
.751
.777
.524
.722
.706
.847
16.7
17.6
17.6
19.4
20.6
19.1
15.07
14.8
14.8
17.9
17.2
18.1
.651
.397
.432
.672
.339
.768
13.9
15.9
15.2
20.0
20.7
19.2
16.9
14.6
16.3
18.9
19.2
20.7
15.5
19.5
11.5
15.9
14.5
15.1
.670
.705
.758
.631
.334
.438
Emotional State
Anxiety HADS 33.4 34.8 37.0 .829 29.7 37.0 .151 34.5 34.6 34.4 .999
Depression HADS 37.2 27.2 33.2 .292 32.3 35.6 .516 35.2 33.9 34.2 .970
PPD dominant hand 34.6 29.2 27.3 .373 25.2 35.4 .036* 33.5 34.4 23.8 .223Motor Speed
PPD non-dominant hand 32.3 26.2 33.1 .590 26.9 33.9 .151 34.2 31.4 25.8 .403
Note: occl. = occlusion; sympt. = symptomatic; asympt = asymptomatic; bilat = bilateral; *p <0.05 significant group differences (Kruskal-Wallis test); TMT A: Trail making
test Part A; TMT B: Trail making test Part B; PPD: Purdue Pegboard; HADS: Hospital Anxiety and Depression Scale
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the small sample size of the subgroups asks for caution
when interpreting these results. Nevertheless, in line with
our results, a previous study found no association between
the intima-media thickness of the common artery and cog-
nition, even when adjusting for vascular risk factors [5].
These data suggest that the intima-media thickness is more
likely to be a marker for underlying risk factors and gen-
eralised atherosclerosis than a direct cause of cognitive
impairment.
Impairment of left-hemisphere functions such as language
is expected to occur more often in patients with left-hemi-
sphere stenosis while impairment of visuospatial abilities
relates to right-hemisphere stenosis [6, 11]. In our study, no
such association was observed, as was also shown in some
older studies [23, 24]. A possible explanation for the miss-
ing structure-to-function relationship is the presence of ef-
ficient collateral blood supply, allowing for good cognitive
functions even in brain regions with reduced blood flow.
However, despite the small sample size of the subgroups,
the present study suggests no influence of the presence of
collateral blood supply on cognitive performance. Hence,
the CAS might be a marker for vascular disease and its risk
factors, and therefore not be directly associated with cog-
nitive performance itself.
Our results indicate that the absence of neurological events
does not guarantee normal cognitive performance in pa-
tients with CAS. Also in previous studies including asymp-
tomatic patients with CAS [4, 25], significantly lower at-
tention, processing speed, learning, reasoning, memory and
motor functions was reported independent of the presence
of brain lesions. Cognitive impairment in asymptomatic pa-
tients may be a marker for an increased risk for stroke [26]
and for progression to dementia [27], institutionalisation
and mortality [28]. Many asymptomatic patients with CAS
are therefore not truly ‘normal’ from a neuropsychological
point of view.
Cerebrovascular risk factors were related to worse cognit-
ive performance in our study. Interestingly, hypercholester-
olemia was associated with better verbal and visual episod-
ic memory. We suggest that it is not the risk factor of hy-
percholesterolemia per se that influences episodic memory,
but rather the pharmaceutical treatment of this risk factor.
Statins are often given to treat hypercholesterolemia (in
87% of our sample). A possible positive effect of statins
on episodic memory was previously suggested in a study
of 37 elderly patients, all treated with statins for >15 years
[29]. Patients receiving long-term statin therapy exhibited
better verbal episodic memory than controls, and this as-
sociation became even more pronounced with longer statin
therapy. Our study results support the potential positive ef-
fect of statins on verbal and visual episodic memory.
Mechanisms underlying cognitive impairment in patients
with CAS remain uncertain. Carotid stenosis may act as
a marker of intracerebral atherosclerosis leading to micro-
circulatory disturbances that are likely to influence cognit-
ive performance. Small-vessel disease and lacunar infarc-
tions arising from silent micro-embolism (which has been
noted with carotid stenosis of >70%) affecting subcortical
structures and deep white matter is additionally suggested
to have an impact on cognitive performance. Silent infarc-
tions are detected in 15 to 19% of patients with asympto-
matic stenosis [30]. Spontaneous cerebral emboli are asso-
ciated with a decline of cognitive performance in patients
with dementia [31] and may have influenced cognitive per-
formance in our patients. In patients with CAS, atrophy
of the corpus callosum is suggested to be associated with
cognitive impairment and with changes in haemodynam-
ic features [1]. Cortical disconnection may be an important
factor in the development of cognitive impairment in pa-
tients without large cortical lesions.
When interpreting the present findings, one has to consider
that our results are based on a heterogeneous group of pa-
tients with carotid artery stenosis which increases the gen-
eralisability of results. However, only patients with enough
time for a neuropsychological assessment before treating
the CAS were included. Hence, there might be a bias to-
wards less severe cases of patients with CAS.
Among the limitations of the study is the likelihood of
bias of study results due to multiple comparisons. Since
some neuropsychological tests are inter-related, they may
influence one-another (i.e. intercorrelation between differ-
ent tests of executive functions such as processing speed
measured with the TMT and motor speed). This is why
the Bonferroni correction has to be critically questioned
and is referred to in table 4. The degree of stenosis was
not directly associated with cognitive performance level in
our study. The variable ‘degree of stenosis’ was used as
a categorical variable, divided in three categories, result-
ing in small sample size per category. Treating the variable
as a continuous variable and correlating it with continuous
cognitive performance scores might reveal different results.
In this prospective study, we only included patients with
enough time for a neuropsychological assessment before
intervention; hence there might be a bias in patient selec-
tion.
Our results point towards a generally high sensitivity of
standardised cognitive assessment tools – possibly higher
than that of cerebral MR imaging – for detecting early
signs of atherosclerosis. Since the blood supply to the brain
is thought to be associated with cognitive functioning it
would be interesting to quantify the blood supply by means
of positron emission tomography (PET), dynamic
susceptibility-weighted contrast-enhanced perfusion MR
or even more specifically, arterial spin labelling, and to
compare these data with cognitive functioning in a future
study.
Recently it was proposed that treatment with transcervical
carotid artery stenting with flow reversal leads to a signific-
ant increase in cognition, regardless of baseline risk factors
(e.g. hypertension, diabetes mellitus, dyslipidemia). The
increase was particularly evident in processing speed, lan-
guage, memory, and visuospatial functions [3]. Other stud-
ies have not been able to draw a clear conclusion regarding
the impact of interventions such as carotid endarterectomy
[32] or carotid artery stenting [33] upon cognition. Since
our data present no direct link between the degree of ca-
rotid stenosis or the presence of collaterals and cognit-
ive impairment, it remains to be determined in a future
study how carotid interventions such as revascularisation
(i.e. stenting or endarterectomy) change neuropsychologic-
al performance levels. The present study contributes to
more detailed knowledge about the cognitive and emotion-
Original article Swiss Med Wkly. 2014;144:w13970
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al state of patients with carotid artery disease and may im-
prove counselling, interpretation of symptoms and taking
care of these patients.
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